Eskender Beyene, MD
Critical Care Medicine · Herndon, VANPI 1982642518
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,984 of the $4,395 with a category attached, or 67.9%. Inspire Medical Systems, Inc. accounts for 81.6% of it on its own, with 4 other manufacturers making up the rest.
Across 25 payments — averaging $175.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$4K
- ZOLL Respicardia, Inc.$596
- Pfizer$100
- Philips North America LLC$96
- Jazz Pharmaceuticals Inc.$18
Across 2 payments — averaging $666.57 each. An ownership or investment interest held by the physician or an immediate family member.
- Exthera Medical Corporation$1K
What the payments were for
- Travel & lodging$2,98468%
- Food & beverage$1,41132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 20 | $3,585 |
| ZOLL Respicardia, Inc. | 2 | $596 |
| Pfizer | 1 | $100 |
| Philips North America LLC | 1 | $96 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$2,072
- Inspire$1,050
- remede System$575
- ELIQUIS$100
How this compares
$4,395 in reported general payments places this provider in the 85th percentile of 174 critical care medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate ErZolpidem Tartrate | 16 | $644 |
| Zolpidem Tartrate | 16 | $111 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Herndon
- Oksana ShlobinFalls Church$375K
- Matthew WilliamsAnnandale$235K
- Sami Abdul JawadFalls Church$193K
- Rajiv MalhotraRichmond$187K
- Thomas BouderWinchester$163K
- Christopher KingFalls Church$131K
- Rohit GoyalFredericksburg$95K
- Robert ThieleCharlottesville$52K
- Jeff HalesArlington$37K
- Paul MarikNorfolk$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.